Gayatri Bharadhwaj
Gastroenterology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Gayatri Bharadhwaj’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A51648 · Current
Licensed to practise in California · since 1993 · expires 2028-08-31 · University of Madras, Madras Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Drugs they prescribed that Part D paid
$134,071
Pharmacies billed $134,071 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 505) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
416 generic and 89 brand-name prescriptions · $134,071 in drug cost · 37 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 11 | $25,580 | $2,325 |
| Mesalamine | 24 | $14,845 | $619 |
| Motegrity | 22 | $14,240 | $647 |
| Gavilyte-C | 111 | $2,537 | $23 |
| Cholestyramine | 43 | $2,060 | $48 |
See all 8 drugs
| Xifaxan | 11 | $25,580 | $2,325 |
| Mesalamine | 24 | $14,845 | $619 |
| Motegrity | 22 | $14,240 | $647 |
| Gavilyte-C | 111 | $2,537 | $23 |
| Cholestyramine | 43 | $2,060 | $48 |
| Pantoprazole | 124 | $1,584 | $13 |
| Famotidine | 48 | $756 | $16 |
| Sucralfate | 13 | $561 | $43 |
Year by year
| 2024 | 505 | 256 | 0% (0) | 18% | $134,071 |
| 2023 | 589 | 346 | 0% (0) | 23% | $135,494 |
| 2022 | 565 | 337 | 0% (0) | 25% | $104,548 |
| 2021 | 613 | 388 | 0% (0) | 24% | $101,347 |
| 2020 | 522 | 300 | 0% (0) | 23% | $93,700 |
| 2019 | 544 | 354 | 0% (0) | 14% | $83,672 |
| 2018 | 476 | 315 | 0% (0) | 37% | $88,205 |
| 2017 | 489 | 270 | 0% (0) | 18% | $102,703 |
| 2016 | 479 | 266 | 0% (0) | 22% | $118,662 |
| 2015 | 374 | 208 | None | 17% | $76,448 |
| 2014 | 349 | 192 | None | 18% | $83,668 |
| 2013 | 259 | 123 | None | None | $74,115 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Xifaxan | 21 | $47,095 | $2,243 |
| Motegrity | 26 | $22,947 | $883 |
| Lialda | 22 | $12,440 | $565 |
| Gavilyte-C | 208 | $4,386 | $21 |
| Mesalamine | 12 | $2,715 | $226 |
| Cholestyramine | 39 | $1,494 | $38 |
| Pantoprazole | 104 | $1,426 | $14 |
| Famotidine | 32 | $582 | $18 |
| Peg-3350 and Electrolytes | 15 | $401 | $27 |
2022: 10 drugs
| Xifaxan | 12 | $23,650 | $1,971 |
| Lialda | 30 | $17,047 | $568 |
| Zenpep | 11 | $14,148 | $1,286 |
| Motegrity | 12 | $12,123 | $1,010 |
| Gavilyte-C | 154 | $2,694 | $17 |
| Pantoprazole | 118 | $1,839 | $16 |
| Cholestyramine | 33 | $1,336 | $40 |
| Peg-3350 and Electrolytes | 39 | $803 | $21 |
| Sucralfate | 11 | $798 | $73 |
| Famotidine | 21 | $373 | $18 |
2021: 12 drugs
| Lialda | 44 | $27,427 | $623 |
| Xifaxan | 14 | $26,172 | $1,869 |
| Linzess | 12 | $14,239 | $1,187 |
| Peg-3350 and Electrolytes | 110 | $2,233 | $20 |
| Gavilyte-C | 135 | $2,065 | $15 |
| Pantoprazole | 94 | $1,589 | $17 |
| Cholestyramine | 33 | $1,571 | $48 |
| Budesonide Ec | 11 | $1,122 | $102 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 11 | $769 | $70 |
| Peg 3350-Electrolyte | 26 | $724 | $28 |
| Sulfasalazine | 11 | $441 | $40 |
| Famotidine | 21 | $288 | $14 |
2020: 13 drugs
| Lialda | 18 | $14,612 | $812 |
| Zenpep | 13 | $13,852 | $1,066 |
| Mesalamine | 19 | $7,834 | $412 |
| Gavilyte-C | 127 | $2,498 | $20 |
| Budesonide Ec | 21 | $2,466 | $117 |
| Pantoprazole | 102 | $1,785 | $18 |
| Cholestyramine | 14 | $736 | $53 |
| Sulfasalazine | 13 | $666 | $51 |
| Peg-3350 and Electrolytes | 30 | $648 | $22 |
| Peg 3350-Electrolyte | 13 | $351 | $27 |
| Famotidine | 28 | $325 | $12 |
| Amitriptyline | 11 | $125 | $11 |
| Ciprofloxacin | 19 | $117 | $6 |
2019: 10 drugs
| Lialda | 16 | $21,304 | $1,332 |
| Zenpep | 15 | $13,247 | $883 |
| Gavilyte-C | 236 | $8,446 | $36 |
| Ursodiol | 17 | $1,776 | $104 |
| Pantoprazole | 87 | $1,726 | $20 |
| Cholestyramine | 14 | $973 | $69 |
| Sulfasalazine | 13 | $677 | $52 |
| Famotidine | 27 | $469 | $17 |
| Prednisone | 11 | $233 | $21 |
| Ciprofloxacin | 14 | $85 | $6 |
2018: 7 drugs
| Lialda | 20 | $36,146 | $1,807 |
| Peg 3350-Electrolyte | 109 | $3,953 | $36 |
| Gavilyte-C | 101 | $3,719 | $37 |
| Pantoprazole | 89 | $2,537 | $29 |
| Sulfasalazine | 16 | $906 | $57 |
| Famotidine | 32 | $834 | $26 |
| Ciprofloxacin | 11 | $67 | $6 |
2017: 7 drugs
| Lialda | 21 | $28,502 | $1,357 |
| Gavilyte-C | 172 | $2,936 | $17 |
| Pantoprazole | 99 | $2,912 | $29 |
| Sulfasalazine | 21 | $1,738 | $83 |
| Famotidine | 40 | $1,299 | $32 |
| Prednisone | 12 | $360 | $30 |
| Ciprofloxacin | 13 | $86 | $7 |
2016: 8 drugs
| Lialda | 29 | $34,601 | $1,193 |
| Canasa | 11 | $3,531 | $321 |
| Pantoprazole | 88 | $3,173 | $36 |
| Gavilyte-C | 166 | $2,834 | $17 |
| Sulfasalazine | 14 | $1,442 | $103 |
| Famotidine | 26 | $988 | $38 |
| Omeprazole | 14 | $709 | $51 |
| Prednisone | 14 | $456 | $33 |
2015: 7 drugs
| Lialda | 18 | $18,079 | $1,004 |
| Pantoprazole | 90 | $3,124 | $35 |
| Gavilyte-C | 122 | $2,074 | $17 |
| Sulfasalazine | 12 | $1,195 | $100 |
| Omeprazole | 19 | $1,135 | $60 |
| Famotidine | 14 | $470 | $34 |
| Prednisone | 13 | $423 | $33 |
2014: 6 drugs
| Lialda | 20 | $21,095 | $1,055 |
| Carafate | 13 | $4,931 | $379 |
| Pantoprazole | 79 | $2,642 | $33 |
| Gavilyte-C | 102 | $1,758 | $17 |
| Diphenoxylate-Atropine | 16 | $1,123 | $70 |
| Omeprazole | 20 | $1,092 | $55 |
2013: 5 drugs
| Nexium | 31 | $21,430 | $691 |
| Canasa | 11 | $7,748 | $704 |
| Omeprazole | 31 | $1,560 | $50 |
| Pantoprazole | 41 | $1,512 | $37 |
| Gavilyte-C | 25 | $423 | $17 |
Professional record
- NPI
- 1851476519
- Licence
- CA A51648California A51648: Current · expires 2028-08-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A516480
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-25
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.